COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,536 Articles (22,881 medRxiv, 8,655 bioRxiv)

Most recent first Previous |  Page 2993: Articles 29921-29930  | Next

Comparative Analysis of COVID-19 Transmission Patterns in Three Chinese Regions vs. South Korea,Italy and Iran
He, J., Chen, G., Jiang, Y., Jin, R., He, M., Shortridge, A., Wu, J., Christakos, G.
10.1101/2020.04.09.20053223 — Posted: 2020-04-14
Calcium channel blocker amlodipine besylate is associated with reduced case fatality rate of COVID-19 patients with hypertension
Zhang, L., Sun, Y., Zeng, H.-L., Peng, Y., Jiang, X., Shang, W.-J., Wu, Y., Li, S., Zhang, Y.-L., Yang, L., Chen, H., Jin, R., Liu, W., Li, H., Peng, K., Xiao, G.
10.1101/2020.04.08.20047134 — Posted: 2020-04-14 Discussion: Onsite
COVID-19: Recovering estimates of the infected fatality rate during an ongoing pandemic through partial data
Villa, M., Myers, J. F., Turkheimer, F.
10.1101/2020.04.10.20060764 — Posted: 2020-04-14
A Stratified Model to Quantify the Effects of Containment Policies on the Spread of COVID-19
Bokharaie, V. S.
10.1101/2020.04.10.20060681 — Posted: 2020-04-14
COVID-19 lockdowns cause global air pollution declines with implications for public health risk
Venter, Z. S., Aunan, K., Chowdhury, S., Lelieveld, J.
10.1101/2020.04.10.20060673 — Posted: 2020-04-14
Chaos, Percolation and the Coronavirus Spread: the Italian case
Bonasera, A., Bonasera, G., Zhang, S.
10.1101/2020.04.10.20060616 — Posted: 2020-04-14
Potency and timing of antiviral therapy as determinants of duration of SARS CoV-2 shedding and intensity of inflammatory response
Goyal, A., Cardozo-Ojeda, E. F., Schiffer, J. T.
10.1101/2020.04.10.20061325 — Posted: 2020-04-14 Discussion: Onsite
No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial
Mahevas, M., Tran, V.-T., Roumier, M., Chabrol, A., Paule, R., Guillaud, C., Gallien, S., Lepeule, R., Szwebel, T.-A., Lescure, X., Schlemmer, F., Matignon, M., Khellaf, M., Crickx, E., Terrier, B., Morbieu, C., Legendre, P., Dang, J., Schoindre, Y., Pawlotski, J.-M., Michel, M., Perrodeau, E., Carlier, N., Roche, N., De Lastours, V., Mouthon, L., Audureau, E., Ravaud, P., Godeau, B., Costedoat, N.
10.1101/2020.04.10.20060699 — Posted: 2020-04-14 Discussion: Onsite | Offsite
Protecting our health care workers while protecting our communities during the COVID-19 pandemic: a comparison of approaches and early outcomes in two Italian regions, Italy, 2020
Binkin, N., Salmaso, S., Michieletto, F., Russo, F.
10.1101/2020.04.10.20060707 — Posted: 2020-04-14
Risk Assessment of nCOVID-19 Pandemic In India: A Mathematical Model And Simulation
Biswas, S., Mukherjee, M.
10.1101/2020.04.10.20060830 — Posted: 2020-04-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).